Pavoda's novel SafelyFlush device and consumable reduce C. difficile and norovirus infections in hospitals and are used on existing industrial toilets.
C. difficile is the largest source of hospital-acquired infections in the U.S. It is also a challenging bacteria to treat due to its chemically resistant spores, which remain in the environment for months. Infected patients shed billions of spores in their stool, and toilet flushing aerosolizes the spores. Pavoda’s SafelyFlush© technology infuses a proprietary chemical during each flush, reduces aerosols and kills bacteria, spores, and viruses.